Years of life that could be saved from prevention of hepatocellular carcinoma

The incidence of hepatocellular carcinoma is reduced in patients with chronic hepatitis B on long-term nucleos(t)ide analogue therapy

(2014) C. S. Coffin et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Years of life lost as a measure of cancer burden on a national level

(2014) O T Brustugun et al.   BRITISH JOURNAL OF CANCER

Estimation of lead-time bias and its impact on the outcome of surveillance for the early diagnosis of hepatocellular carcinoma

(2014) Alessandro Cucchetti et al.   JOURNAL OF HEPATOLOGY

Daclatasvir plus Sofosbuvir for Previously Treated or Untreated Chronic HCV Infection

(2014) Mark S. Sulkowski et al.   NEW ENGLAND JOURNAL OF MEDICINE

Expected years of life lost for six potentially preventable cancers in the United States

(2013) Pang-Hsiang Liu et al.   PREVENTIVE MEDICINE

Epidemiology of Viral Hepatitis and Hepatocellular Carcinoma

(2012) Hashem B. El-Serag   GASTROENTEROLOGY

Cost-effectiveness of semi-annual surveillance for hepatocellular carcinoma in cirrhotic patients of the Italian Liver Cancer population

(2012) Alessandro Cucchetti et al.   JOURNAL OF HEPATOLOGY

The Incidence and Epidemiology of Hepatocellular Carcinoma: A Global and Regional Perspective

(2010) A. P. Venook et al.   ONCOLOGIST

The global burden of cancer: priorities for prevention

(2009) M. J. Thun et al.   CARCINOGENESIS

Correcting for Lead Time and Length Bias in Estimating the Effect of Screen Detection on Cancer Survival

(2008) S. W. Duffy et al.   AMERICAN JOURNAL OF EPIDEMIOLOGY

Systematic Review: Health-State Utilities in Liver Disease: A Systematic Review

(2008) David J. McLernon et al.   MEDICAL DECISION MAKING

Estimation of Life Expectancy and the Expected Years of Life Lost in Patients with Major Cancers: Extrapolation of Survival Curves under High-Censored Rates

(2008) Po-Ching Chu et al.   VALUE IN HEALTH